Table 4 Number of visits in which there are discrepancies in DAS components in patients with moderate/high disease activity that did not receive treatment intensification
From: DAS steered therapy in clinical practice; cross-sectional results from the METEOR database
DAS > 2.4 and medication not increased | ||
|---|---|---|
Total | ||
SJC ≤1 and TJC ≥2, N (%) | 201 (19.6) | 1028 |
SJC ≤1 and VASpt ≥20, N (%) | 198 (19.3) | 1028 |
SJC ≤1 and ESR ≥28, N (%) | 98 (9.5) | 1027 |
VASpt ≥20 mm higher than VASphys N (%) | 148 (32.9) | 450 |
VASphys ≥ 20 mm higher than VASpt, N (%) | 25 (5.6) | 450 |